The market for chimeric antigen receptor T cell therapies

Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering

Billingsley, M. M., Singh, N., Ravikumar, P., Zhang, R., June, C. H., & Mitchell, M. J. (2020) · Nano Letters · doi:10.1021/acs.nanolett.9b04246 · Cited by 636 · see citing works

Recent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy

Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2020) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 452 · see citing works

Recent Progresses in Phototherapy‐Synergized Cancer Immunotherapy

Ng, C. W., Li, J., & Pu, K. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201804688 · Cited by 352 · see citing works

The approved gene therapy drugs worldwide: from 1998 to 2019

Ma, C., Wang, Z.-L., Xu, T., He, Z., & Wei, Y.-Q. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107502 · Cited by 331 · see citing works

Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy

Abou-el-Enein, M., Elsallab, M., Feldman, S. A., Fesnak, A. D., Heslop, H. E., Marks, P., Till, B. G., Bauer, G., & Savoldo, B. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0084 · Cited by 321 · see citing works

Nanomaterial-Based Tumor Photothermal Immunotherapy

Xu, P., & Liang, F. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s249252 · Cited by 200 · see citing works

Applications of synthetic biology in medical and pharmaceutical fields

Yan, X., Liu, X., Zhao, C., & Chen, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01440-5 · Cited by 184 · see citing works

PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges

McGowan, E. M., Lin, Q., Ma, G., Yin, H., Chen, S., & Lin, Y. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109625 · Cited by 174 · see citing works

AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia

Nawaz, W., Huang, B., Xu, S., Li, Y., Zhu, L., Hu, Y., Wu, Z., & Wu, X. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00508-1 · Cited by 170 · see citing works

Targeted modulation of immune cells and tissues using engineered biomaterials

Yousefpour, P., Ni, K., & Irvine, D. J. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00016-2 · Cited by 169 · see citing works

Cell therapies in the clinic

Wang, L. L., Janes, M. E., Kumbhojkar, N., Kapate, N., Clegg, J. R., Prakash, S., Heavey, M. K., Zhao, Z., Anselmo, A. C., & Mitragotri, S. (2021) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10214 · Cited by 162 · see citing works

Nanomedicine‐Boosting Tumor Immunogenicity for Enhanced Immunotherapy

Huang, J., Yang, B., Peng, Y., Huang, J., Wong, S. H. D., Bian, L., Zhu, K., Shuai, X., & Han, S. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202011171 · Cited by 157 · see citing works

A new era of cancer phototherapy: mechanisms and applications

Wang, Y., Ma, K., Kang, M., Yan, D., Niu, N., Yan, S., Sun, P., Zhang, L., Sun, L., Wang, D., et al. (2024) · Chemical Society Reviews · doi:10.1039/d4cs00708e · Cited by 157 · see citing works

Eradication of Hepatocellular Carcinoma by NKG2D-Based CAR-T Cells

Sun, B., Yang, D., Dai, H., Liu, X., Jia, R., Cui, X., Li, W., Cai, C., Xu, J., & Zhao, X. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0026 · Cited by 146 · see citing works

Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines

Chatzikleanthous, D., O’Hagan, D. T., & Adamo, R. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00447 · Cited by 150 · see citing works

Therapeutic potential of CAR T cell in malignancies: A scoping review

Mehrabadi, A. Z., Ranjbar, R., Farzanehpour, M., Shahriary, A., Dorostkar, R., Hamidinejad, M. A., & Ghaleh, H. E. G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112512 · Cited by 111 · see citing works

Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications

Li, Y., Glass, Z., Huang, M., Chen, Z., & Xu, Q. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119711 · Cited by 113 · see citing works

Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?

Hosseinkhani, N., Derakhshani, A., Kooshkaki, O., Shadbad, M. A., Hajiasgharzadeh, K., Baghbanzadeh, A., Safarpour, H., Mokhtarzadeh, A., Brunetti, O., Yue, S. C., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218305 · Cited by 110 · see citing works

Circularly permuted LOV2 as a modular photoswitch for optogenetic engineering

He, L., Tan, P., Zhu, L., Huang, K., Nguyen, N. T., Wang, R., Guo, L. M., Li, L., Yang, Y., Huang, Z., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00792-9 · Cited by 102 · see citing works

Engineering Precision Medicine

Sun, W., Lee, J., Zhang, S., Benyshek, C., Dokmeci, M. R., & Khademhosseini, A. (2018) · Advanced Science · doi:10.1002/advs.201801039 · Cited by 93 · see citing works

The next wave of cellular immunotherapies in pancreatic cancer

Yeo, D., Giardina, C., Saxena, P., & Rasko, J. E. J. (2022) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2022.01.010 · Cited by 91 · see citing works

CAR‐T Cell Therapy in Cancer: Tribulations and Road Ahead

Zhang, Q., Ping, J., Huang, Z., Zhang, X., Zhou, J., Wang, G., Shaoyang, L., & Ma, J. (2020) · Journal of Immunology Research · doi:10.1155/2020/1924379 · Cited by 86 · see citing works

Quantitative Systems Pharmacology Model of Chimeric Antigen Receptor T‐Cell Therapy

Hardiansyah, D., & Ng, C. M. (2019) · Clinical and Translational Science · doi:10.1111/cts.12636 · Cited by 79 · see citing works

Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy

Han, S., Huang, K., Gu, Z., & Wu, J. (2019) · Nanoscale · doi:10.1039/c9nr08086d · Cited by 79 · see citing works

Target selection of CAR T cell therapy in accordance with the TME for solid tumors.

Liu, B., Yan, L., & Zhou, M. (2019) · Europe PMC (PubMed Central) · Cited by 78 · see citing works

Promises and challenges of a decentralized CAR T-cell manufacturing model

Shah, M., Krull, A., Odonnell, L., de Lima, M. J., & Bezerra, E. (2023) · Frontiers in Transplantation · doi:10.3389/frtra.2023.1238535 · Cited by 77 · see citing works

Next-generation drug repurposing using human genetics and network biology

Nabirotchkin, S., Peluffo, A. E., Rinaudo, P., Yu, J., Hajj, R., & Cohen, D. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.12.004 · Cited by 76 · see citing works

Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based Therapeutics

Teixeira, A. P., & Fussenegger, M. (2023) · Advanced Science · doi:10.1002/advs.202309088 · Cited by 76 · see citing works

The molecularly imprinted polymer essentials: curation of anticancer, ophthalmic, and projected gene therapy drug delivery systems

Tuwahatu, C. A., Yeung, C. C., Lam, Y. W., & Roy, V. A. L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.023 · Cited by 76 · see citing works

Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells

Xie, Y., Xie, F., Zhang, L., Zhou, X., Huang, J., Wang, F., Jin, J., Zhang, L., Zeng, L., & Zhou, F. (2021) · Advanced Science · doi:10.1002/advs.202101672 · Cited by 71 · see citing works

Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma

Cui, J., Zhang, Q., Song, Q., Wang, H., Dmitriev, P., Sun, M., Cao, X., Wang, Y., Guo, L., Indig, I. H., et al. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz117 · Cited by 71 · see citing works

Lentiviral vector bioprocess economics for cell and gene therapy commercialization

Comisel, R.-M., Kara, B., Fiesser, F. H., & Farid, S. S. (2020) · Biochemical Engineering Journal · doi:10.1016/j.bej.2020.107868 · Cited by 71 · see citing works

Observation and quantification of the morphological effect of trypan blue rupturing dead or dying cells

Chan, L. L., Rice, W. L., & Qiu, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227950 · Cited by 68 · see citing works

The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors

Deng, C., Zhao, J., Zhou, S., Dong, J., Cao, J., Gao, J., Bai, Y., & Deng, H. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.10.010 · Cited by 66 · see citing works

Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer

Jaén, M., Martín‐Regalado, Á., Bartolomé, R. A., Robles, J., & Casal, J. I. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188802 · Cited by 62 · see citing works

Engineering Nano‐Therapeutics to Boost Adoptive Cell Therapy for Cancer Treatment

Zheng, C., Zhang, J., Chan, H. F., Hu, H., Lv, S., Na, N., Tao, Y., & Li, M. (2021) · Small Methods · doi:10.1002/smtd.202001191 · Cited by 61 · see citing works

STING-activating drug delivery systems: Design strategies and biomedical applications

Li, C., Zhang, Y., Wan, Y., Wang, J., Lin, J., Li, Z., & Huang, P. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.01.001 · Cited by 57 · see citing works

Emerging CAR T Cell Strategies for the Treatment of AML

Vishwasrao, P., Li, G., Boucher, J. C., Smith, D. L., & Hui, S. K. (2022) · Cancers · doi:10.3390/cancers14051241 · Cited by 59 · see citing works

Chimeric Antigen Receptor T-Cell Therapy in Glioblastoma: Current and Future

Li, L., Zhu, X., Yu, Q., Yuan, X., Ding, Y., Hu, D., He, X., & Wu, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594271 · Cited by 55 · see citing works

Lipoplex‐Mediated Single‐Cell Transfection via Droplet Microfluidics

Li, X., Aghaamoo, M., Liu, S., Lee, D., & Lee, A. P. (2018) · Small · doi:10.1002/smll.201802055 · Cited by 56 · see citing works

Nanobodies: The Future of Antibody-Based Immune Therapeutics

Bathula, N. V., Bommadevara, H., & Hayes, J. M. (2020) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.3941 · Cited by 55 · see citing works

Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One

Salerno, A., Seghetti, F., Caciolla, J., Uliassi, E., Testi, E., Guardigni, M., Roberti, M., Milelli, A., & Bolognesi, M. L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00302 · Cited by 55 · see citing works

Engineering cells for therapy and diagnosis

Li, Z., Wang, Y., Gu, Z., & Hu, Q. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00198-x · Cited by 55 · see citing works

Advances in Engineering Cells for Cancer Immunotherapy

Xu, X., Li, T., Shen, S., Wang, J., Abdou, P., Gu, Z., & Mo, R. (2019) · Theranostics · doi:10.7150/thno.38583 · Cited by 53 · see citing works

Optimization of CAR-T Cell-Based Therapies Using Small-Molecule-Based Safety Switches

Zheng, Y., Nandakumar, K. S., & Cheng, K. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02054 · Cited by 54 · see citing works

Therapeutic cell engineering: designing programmable synthetic genetic circuits in mammalian cells

Mansouri, M., & Fussenegger, M. (2021) · Protein & Cell · doi:10.1007/s13238-021-00876-1 · Cited by 52 · see citing works

Native Mitochondria-Targeting polymeric nanoparticles for mild photothermal therapy rationally potentiated with immune checkpoints blockade to inhibit tumor recurrence and metastasis

Zhang, Y., He, X., Zhang, Y., Zhao, Y., Lu, S., Peng, Y., Lu, L., Hu, X., & Zhan, M. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130171 · Cited by 52 · see citing works

Delivery of Plasmid DNA by Ionizable Lipid Nanoparticles to Induce CAR Expression in T Cells

Prazeres, P. H. D. M., Ferreira, H. A. S., Costa, P. A. C., da Silva, W., Alves, M. T. R., Padilla, M. S., Thatte, A. S., Santos, A. K., Lobo, A. O., Sabino, A. D. P., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s424723 · Cited by 47 · see citing works

Peptide Delivery Systems for Cancer Vaccines

He, X., Abrams, S. I., & Lovell, J. F. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800060 · Cited by 45 · see citing works

CAR T cells: engineered immune cells to treat brain cancers and beyond

Huang, Z., Dewanjee, S., Chakraborty, P., Jha, N. K., Dey, A., Gangopadhyay, M., Chen, X.-Y., Wang, J., & Jha, S. K. (2023) · Molecular Cancer · doi:10.1186/s12943-022-01712-8 · Cited by 45 · see citing works

Trispecific antibodies for cancer immunotherapy

Yao, Y., Hu, Y., & Wang, F. (2023) · Immunology · doi:10.1111/imm.13636 · Cited by 40 · see citing works

CARs: Beyond T Cells and T Cell-Derived Signaling Domains

Sievers, N. M., Dörrie, J., & Schaft, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103525 · Cited by 40 · see citing works

Macrophage‐Mediated Delivery of Hypoxia‐Activated Prodrug Nanoparticles

Evans, M. A., Shields, C. W., Krishnan, V., Wang, L., Zhao, Z., Ukidve, A., Lewandowski, M., Gao, Y., & Mitragotri, S. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201900162 · Cited by 39 · see citing works

Lactate Dehydrogenase A Depletion Alters MyC-CaP Tumor Metabolism, Microenvironment, and CAR T Cell Therapy

Mane, M. M., Cohen, I., Ackerstaff, E., Shalaby, K., Ijoma, J. N., Ko, M. K., Maeda, M., Albeg, A. S., Vemuri, K., Satagopan, J. M., et al. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.07.006 · Cited by 37 · see citing works

The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape

Lyu, L., Feng, Y., Chen, X., & Yuanjia, H. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-00749-8 · Cited by 37 · see citing works

Advanced Cell Therapies for Glioblastoma

Wang, G., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.904133 · Cited by 38 · see citing works

Biomaterials in Chimeric Antigen Receptor T‑Cell Process Development

Cardle, I. I., Cheng, E. L., Jensen, M. C., & Pun, S. H. (2020) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00335 · Cited by 35 · see citing works

Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy

Salinas, R. D., Durgin, J. S., & O’Rourke, D. M. (2020) · CNS Drugs · doi:10.1007/s40263-019-00687-3 · Cited by 34 · see citing works

Polymeric Systems for Cancer Immunotherapy: A Review

Le, T. M. D., Yoon, A. R., Thambi, T., & Yun, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.826876 · Cited by 33 · see citing works

Considerations for setting occupational exposure limits for novel pharmaceutical modalities

Graham, J. C., Hillegass, J., & Schulze, G. E. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104813 · Cited by 32 · see citing works

Bi-specific ligand-controlled chimeric antigen receptor T-cell therapy for non-small cell lung cancer

Chu, W., Zhou, Y., Tang, Q., Wang, M., Ji, Y., Yan, J., Yin, D., Zhang, S., Lu, H., & Shen, J. (2018) · BioScience Trends · doi:10.5582/bst.2018.01048 · Cited by 31 · see citing works

In Vivo Ultrasound and Photoacoustic Imaging of Nanoparticle-Engineered T Cells and Post-Treatment Assessment to Guide Adoptive Cell Immunotherapy

Kubelick, K. P., Kim, J., Kim, M., Huang, X., Wang, C., Song, S., Younan Xia, A., & Emelianov, S. (2025) · ACS Nano · doi:10.1021/acsnano.4c12929 · Cited by 30 · see citing works

Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy

Dai, X., Ren, L. F., Liu, M., Cai, H., Zhang, H., Gong, Q., Gu, Z., & Luo, K. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101163 · Cited by 29 · see citing works

FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects

Al-ibraheem, A., Abdlkadir, A., Juweid, M., Alrabi, K., Ma'koseh, M., Abdel-Razeq, H., & Mansour, A. (2023) · Cancers · doi:10.3390/cancers15041063 · Cited by 25 · see citing works

Functional Nanomaterials Optimized to Circumvent Tumor Immunological Tolerance

Gong, N., Zhang, Y., Zhang, Z., Li, X., & Liang, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201806087 · Cited by 28 · see citing works

Synthetic Biology in Chimeric Antigen Receptor T (CAR T) Cell Engineering

Zhang, C., Zhuang, Q., Liu, J., & Liu, X. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00256 · Cited by 29 · see citing works

Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies

Singh, H., Srour, S. A., Milton, D. R., McCarty, J. M., Dai, C., Gaballa, M., Ammari, M., Olivares, S., Huls, H. M., Groot, E. D., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1032397 · Cited by 28 · see citing works

Lipid-based nanoparticles for cancer immunotherapy

Fan, S., Han, H., Yan, Z., Lu, Y., He, B., & Zhang, Q. (2023) · Medical Review · doi:10.1515/mr-2023-0020 · Cited by 28 · see citing works

Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors

Yan, L., & Liu, B. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s190336 · Cited by 27 · see citing works

Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme

Lim, X. Y., Capinpin, S. M., Bolem, N., Foo, A. S. C., Yip, G. W., Kumar, A. P., & Teh, D. B. L. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10483 · Cited by 26 · see citing works

Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy

Chen, Y., Zhu, Y., Kramer, A. B., Fang, Y., Wilson, M., Li, Y.-R., & Yang, L. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1135468 · Cited by 26 · see citing works

Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia

Wan, Z., Sun, R., Moharil, P., Chen, J., Liu, Y., Song, X., & Ao, Q. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0620-063rr · Cited by 26 · see citing works

Single Molecule Force Spectroscopy Reveals Distinctions in Key Biophysical Parameters of αβ T-Cell Receptors Compared with Chimeric Antigen Receptors Directed at the Same Ligand

Banik, D., Hamidinia, M., Brzostek, J., Wu, L., Stephens, H. M., MacAry, P. A., Reinherz, E. L., Gascoigne, N. R. J., & Lang, M. J. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c02240 · Cited by 26 · see citing works

Biomaterials for chimeric antigen receptor T cell engineering

Niu, H., Zhao, P., & Sun, W. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.04.043 · Cited by 27 · see citing works

Cellular therapies: Day by day, all the way

Atilla, E., Kılıç, P., & Gürman, G. (2018) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2018.04.019 · Cited by 25 · see citing works

Cost burden of diffuse large B-cell lymphoma

Harkins, R. A., Patel, S. P., & Flowers, C. R. (2019) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2019.1680288 · Cited by 25 · see citing works

Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma

Bao, F., Wan, W., He, T., Qi, F., Liu, G., Hu, K., Lu, X., Yang, P., Dong, F., Wang, J., et al. (2019) · Cancer Gene Therapy · doi:10.1038/s41417-018-0073-7 · Cited by 24 · see citing works

Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression In Vivo

Beck, R. J., Slagter, M., & Beltman, J. B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3147 · Cited by 24 · see citing works

Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses

Mehrabadi, A. Z., Roozbahani, F., Ranjbar, R., Farzanehpour, M., Shahriary, A., Dorostkar, R., & Ghaleh, H. E. G. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02486-x · Cited by 22 · see citing works

Ultrasensitive Detection and Depletion of Rare Leukemic B Cells in T Cell Populations via Immunomagnetic Cell Ranking

Wang, Z., Sargent, E. H., & Kelley, S. O. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04202 · Cited by 19 · see citing works

The synergistic strategies for the immuno‐oncotherapy with photothermal nanoagents

Zhang, Y., Zhang, G., Wang, G., Wu, L., Monteiro-Riviere, N. A., & Li, Y. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1717 · Cited by 20 · see citing works

CAR-T-Cell Therapy: Present Progress and Future strategies

Abbasi, M. H., Riaz, A., Khawar, M. B., Farooq, A., Majid, A., & Sheikh, N. (2022) · Biomedical Research and Therapy · doi:10.15419/bmrat.v9i2.726 · Cited by 18 · see citing works

Gene Targets of CAR-T Cell Therapy for Glioblastoma

Wang, C., Li, Y., Gu, L., Chen, R., Zhu, H., Zhang, X., Zhang, Y., Shi, F., Qiu, S., Jian, Z., et al. (2023) · Cancers · doi:10.3390/cancers15082351 · Cited by 18 · see citing works

Starting points for the development of new targeted therapies for glioblastoma multiforme

Rusak, A., Wiatrak, B., Krawczyńska, K., Górnicki, T., Zagórski, K., Zadka, Ł., & Fortuna, W. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102187 · Cited by 18 · see citing works

Engineered cells as glioblastoma therapeutics

Ramanathan, A., & Lorimer, I. A. J. (2021) · Cancer Gene Therapy · doi:10.1038/s41417-021-00320-w · Cited by 16 · see citing works

Accelerating Diverse Cell-Based Therapies Through Scalable Design

Peterman, E. L., Ploessl, D. S., & Galloway, K. E. (2024) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-100722-121610 · Cited by 15 · see citing works

Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli

Galvan, S., Teixeira, A. P., & Fussenegger, M. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28770 · Cited by 15 · see citing works

Atypical artificial cells: Novel biomimetic materials for combating cancer

Ren, Z., Wan, Q., Zhu, Y., Li, L., Wang, K., Zhao, F., Jiao, K., Tang, M., Tay, F. R., Wan, M., et al. (2024) · Interdisciplinary materials · doi:10.1002/idm2.12199 · Cited by 14 · see citing works

Cord blood-derived CD19-specific chimeric antigen receptor T cells: an off-the-shelf promising therapeutic option for treatment of diffuse large B-cell lymphoma

Yu, T., Luo, C., Zhang, H., Tan, Y., & Li, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1139482 · Cited by 14 · see citing works

Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies

Uliassi, E., Bolognesi, M. L., & Milelli, A. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00733 · Cited by 13 · see citing works

A Cell-Specific Nuclear Factor-Kappa B–Activating Gene Expression Strategy for Delivering Cancer Immunotherapy

Wang, D., Dai, W., & Wang, J. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.093 · Cited by 13 · see citing works

Engineered drug-loaded cells and cell derivatives as a delivery platform for cancer immunotherapy

Wang, L., & Liu, J. (2020) · Biomaterials Science · doi:10.1039/d0bm01676d · Cited by 13 · see citing works

Lipid nanoparticles for engineering next generation CAR T cell immunotherapy

Ang, M. J. Y., Metzloff, A. E., Thatte, A. S., & Mitchell, M. J. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00432b · Cited by 14 · see citing works

High‐Throughput Image Cytometry Detection Method for CAR‐T Transduction, Cell Proliferation, and Cytotoxicity Assays

Wang, Y., Chan, L. L., Grimaud, M., Fayed, A., Zhu, Q. K., & Marasco, W. A. (2020) · Cytometry Part A · doi:10.1002/cyto.a.24267 · Cited by 12 · see citing works

Six events that shaped antibody approvals in oncology

Paul, S., & Zhou, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1533796 · Cited by 11 · see citing works

Tonic Signaling and Its Effects on Lymphopoiesis of CAR-Armed Hematopoietic Stem and Progenitor Cells

Albert, S., Koristka, S., Gerbaulet, A., Cartellieri, M., Arndt, C., Feldmann, A., Berndt, N., Loureiro, L. R., Bonin, M. V., Ehninger, G., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801004 · Cited by 11 · see citing works

Rapid generation of CD19 CAR-T cells by minicircle DNA enables anti-tumor activity and prevents fatal CAR-B leukemia

Ye, X., Wu, Y., Zhang, H., Shi, L., Zhou, Y., Guo, S., Dong, J., & Cai, J. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216278 · Cited by 10 · see citing works

Stabilization of an Infectious Enveloped Virus by Spray-Drying and Lyophilization

Coleman, H. J., Schwartz, D. K., Kaar, J. L., Garcea, R. L., & Randolph, T. W. (2024) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2024.04.012 · Cited by 9 · see citing works

Expanding the cryoprotectant toolbox in biomedicine by multifunctional antifreeze peptides

Hemmati, S. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108545 · Cited by 8 · see citing works

Enabling drug discovery and development through single-cell imaging

Pomerantz, A. K., Sari‐Sarraf, F., Grove, K. J., Pedro, L., Rudewicz, P. J., Fathman, J. W., & Krucker, T. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1559147 · Cited by 8 · see citing works

CAR T-Cell Therapy in Hematological Malignancies

Haslauer, T., Greil, R., Zaborsky, N., & Geisberger, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168996 · Cited by 181 · see citing works

Chimeric antigen receptor T‐cell therapy for haematological malignancies

Selim, A. G., & Tam, C. S. L. (2020) · The Medical Journal of Australia · doi:10.5694/mja2.50783 · Cited by 3 · see citing works

CAR Therapy for T-cell Malignancies

Cinquina, A., Feng, J., Zhang, H., & Ma, Y. (2022) · Journal of Cellular Immunology · doi:10.33696/immunology.4.141 · Cited by 1 · see citing works

Chimeric antigen receptor (CAR) T cell therapy: current landscape, challenges, and future horizons in hematologic and solid tumors

Al-Hussaniy, H. A., Ali, S. S. A., Ahmed, M., Rasheed, H. A., Ali, K. A., Al‐Abdeen, S. H. Z., & Al-tameemi, Z. S. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e173384 · Cited by 2 · see citing works

Special Issue “The Promising Future of CAR-Based Therapies: A Matter of Molecular Details”

Nicolini, F., Montini, O., Zurlo, M., Tettamanti, S., & Mazza, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199587 · Cited by 2 · see citing works